Category: Corona Virus

Page 458«..1020..457458459460..470480..»

UNM Hospital taking part in national study on COVID-19 long haulers – KRQE News 13

October 25, 2021

ALBUQUERQUE, N.M.(KRQE) A stolen Halloween decoration is returned with an apology note. Surveillance video shows a young woman take off with a spider from an elaborate Halloween display at Jessica Killingsworth's house. The spider has since been returned along with an apology note.

In the note, the person admits to being the driver, not the woman seen stealing the spider. The person also says "this isn't like me. It was a spur of the moment decision." KRQE News 13 called a number left on the note, the person said she has since also spoken to the homeowner, in person, to apologize.

Continued here:

UNM Hospital taking part in national study on COVID-19 long haulers - KRQE News 13

China to start vaccinating children to age 3 as cases spread – Associated Press

October 25, 2021

TAIPEI, Taiwan (AP) Children as young as 3 will start receiving COVID-19 vaccines in China, where 76% of the population has been fully vaccinated and authorities are maintaining a zero-tolerance policy toward outbreaks.

China becomes one of the very few countries in the world to start vaccinating children that young against the virus. Cuba, for one, has begun a vaccine drive for children as young as 2. The U.S. and many European countries allow COVID-19 shots down to age 12, though the U.S. is moving quickly toward opening vaccinations to 5- to 11-year-olds.

Local city and provincial level governments in at least five Chinese provinces issued notices in recent days announcing that children ages 3 to 11 will be required to get their vaccinations.

The expansion of the vaccination campaign comes as parts of China take new clampdown measures to try to stamp out small outbreaks. Gansu, a northwestern province heavily dependent on tourism, closed all tourist sites Monday after finding new COVID-19 cases. Residents in parts of Inner Mongolia have been ordered to stay indoors because of an outbreak there.

The National Health Commission reported that 35 new cases of local transmission had been detected over the past 24 hours, four of them in Gansu. An additional 19 cases were found in the Inner Mongolia region, with others scattered around the country.

China has employed lockdowns, quarantines and compulsory testing for the virus throughout the pandemic and has largely stamped out cases of local infection while fully vaccinating 1.07 billion people out of a population of 1.4 billion.

In particular, the government is concerned about the spread of the more contagious delta variant by travelers and about having a largely vaccinated public ahead of the Beijing Olympics in February. Overseas spectators already have been banned from the Winter Games, and participants will have to stay in a bubble separating them from people outside.

Chinas most widely used vaccines, from Sinopharm and Sinovac, have shown efficacy in preventing severe disease and transmission of the virus, based on public data. But the protection they offer against the delta variant has not been answered definitively, although officials say they remain protective.

Hubei, Fujian and Hainan provinces all issued provincial level notices alerting new vaccination requirements, while individual cities in Zhejiang province and Hunan province have also issued similar announcements.

China in June had approved two vaccines Sinopharms from the Beijing Institute of Biological Products and Sinovac for children ages 3 to 17, but it has only been vaccinating those 12 and older. In August, regulators approved another, Sinopharms from the Wuhan Institute of Biological Products.

After the vaccines received domestic approval for children in China, foreign governments began giving the shots to children in their own countries. Cambodia uses both Sinovac and Sinopharms shots in children 6 to 11. Regulators in Chile approved Sinovac for children as young as 6. In Argentina, regulators approved the Sinopharm vaccine for children as young as age 3.

Many developing countries left out of the race to get shots from Western pharmaceutical companies like Pfizer and Moderna bought Chinese vaccines. China has shipped more than 1.2 billion doses as of September, according to its Ministry of Foreign Affairs.

Even with widespread domestic and global use, not every parent is reassured about the vaccine, citing less publicly available data on the shots.

Wang Lu, who lives in the southern city of Fuzhou in Fujian province, said she isnt particularly rushing to get her 3-year-old son vaccinated. Im just not very clear on the vaccines safety profile, so I dont really want to get him vaccinated, at the very least, I dont want to be the first, Wang said.

Sinovac started an efficacy trial with 14,000 child participants across multiple countries in September. Its approval in China was based on smaller phase 1 and phase 2 trials. Sinopharms Beijing shot was also approved based on smaller phase 1 and phase 2 trials. These were published later in peer-reviewed journals.

Other parents said they werent concerned, given that many other people had already gotten the shot.

Wu Cong, a mom of a 7-year old, said her daughters school in Shanghai hadnt yet notified them of any vaccinations.

I think this isnt too different from the flu vaccine, theres already been so many people vaccinated, so I dont have too many worries, said Wu.

___

Associated Press researcher Chen Si in Shanghai contributed to this report.

Read the original here:

China to start vaccinating children to age 3 as cases spread - Associated Press

North Dakota’s active COVID-19 cases fall, down by a third from October peak – Grand Forks Herald

October 25, 2021

The North Dakota Department of Health reported a drop in active cases on a low testing day Monday. Statewide case numbers often fall on Mondays following low weekend testing, but North Dakota has seen a consistent decline in virus positives over the last two weeks following a recent high of over 4,500 active cases on Oct. 6.

North Dakota's delta death toll, however, has continued to mount as statewide virus levels have declined. Virus deaths tend to lag behind case surges, and North Dakota reported four new virus deaths since the end of last week, adding to what has already been the state's deadliest month of the pandemic in 2021.

The health department reports that 92 people have died with COVID-19 in the month of October, a larger count than in August and September combined. Hospital beds remain scarce in the state as health care centers have struggled to balance staffing shortages, rising delta cases and noncoronavirus admissions.

The following are COVID-19 case rates, deaths and hospitalizations tracked by the North Dakota Department of Health as of Monday, Oct. 25. Because all data are preliminary, some numbers and totals may change from one day to the next.

Cass County, which encompasses Fargo, had the most known active cases on Monday, with 677 cases. Burleigh County, which includes Bismarck, had 409 active cases, and Ward County, which includes Minot, had 292.

As of Monday, children under 12, an age group that is not yet eligible to receive the COVID-19 vaccine, accounted for 555 of the state's active cases. More than a quarter of North Dakota's active cases are in residents under 20 years old.

The state's 14-day rolling average positivity rate is 7.0%, down from over 8% earlier this month.

At 173 people, virus hospitalizations remain high in North Dakota, though they have fallen from recent highs in the 200s earlier this month. There were just 17 available staffed ICU beds statewide in the most recent hospital reports to a health department database, with nine ICU beds and nine inpatient beds available between Fargo's three hospitals. There were no available ICU beds or inpatient beds in Bismarck's two hospitals, according to the most recent reporting.

FIRST DOSE ADMINISTERED*: 376,595 (56.5% of population ages 12 and up)

FULL VACCINE COVERAGE*: 351,756 (52.8% of population ages 12 and up)

*These figures come from the state's vaccine dashboard, though the Centers for Disease Control and Prevention, which includes vaccinations performed at federal sites, reports slightly higher vaccination rates.

As a public service, weve opened this article to everyone regardless of subscription status. If this coverage is important to you, please consider supporting local journalism by clicking on the subscribe button in the upper righthand corner of the homepage.

Readers can reach reporter Adam Willis, a Report for America corps member, at awillis@forumcomm.com.

See the article here:

North Dakota's active COVID-19 cases fall, down by a third from October peak - Grand Forks Herald

4 factors that raise the risk of you catching COVID – even if you have been vaccinated – World Economic Forum

October 25, 2021

Two weeks after your second COVID-19 vaccine dose, the protective effects of vaccination will be at their highest. At this point, youre fully vaccinated. If you still get COVID-19 after this point, youve suffered a breakthrough infection. Broadly speaking, breakthrough infections are similar to regular COVID-19 infections in unvaccinated people but there are some differences. Here is what to look out for if youve had both jabs.

According to the COVID Symptom Study, the five most common symptoms of a breakthrough infection are a headache, a runny nose, sneezing, a sore throat and loss of smell. Some of these are the same symptoms that people who havent had a vaccine experience. If you havent been vaccinated, three of the most common symptoms are also a headache, sore throat and runny nose.

However, the two other most common symptoms in the unvaccinated are fever and a persistent cough. These two classic COVID-19 symptoms become much less common once youve had your jabs. One study has found that people with breakthrough infections are 58% less likely to have a fever compared with unvaccinated people. Rather, COVID-19 after vaccination has been described as feeling like a head cold for many.

Vaccinated people are also less likely than unvaccinated people to be hospitalised if they develop COVID-19. Theyre also likely to have fewer symptoms during the initial stages of the illness and are less likely to develop long COVID.

The reasons for the disease being milder in vaccinated people could be because vaccines, if they dont block infection, seem to lead to infected people having fewer virus particles in their body. However, this has yet to be confirmed.

In the UK, research has found that 0.2% of the population or one person in every 500 experiences a breakthrough infection once fully vaccinated. But not everyone is at the same risk. Four things appear to contribute to how well you are protected by vaccination.

The first is the specific vaccine type you received and the relative risk reduction that each type offers. Relative risk reduction is a measure of how much a vaccine reduces the risk of someone developing COVID-19 compared to someone who didnt get vaccinated.

Clinical trials found that the Moderna vaccine reduced a persons risk of developing symptomatic COVID-19 by 94%, while the Pfizer vaccine reduced this risk by 95%. The Johnson & Johnson and AstraZeneca vaccines performed less well, reducing this risk by about 66% and 70% respectively (though protection offered by the AstraZeneca vaccine appeared to rise to 81% if a longer gap was left between doses).

2. Time since vaccination

But these figures dont paint the complete picture. Its becoming increasingly evident that length of time since vaccination is also important and is one of the reasons why the debate over booster immunisations is growing in intensity.

Early research, still in preprint (and so yet to be reviewed by other scientists), suggests that the Pfizer vaccines protection wanes over the six months following vaccination. Another preprint from Israel also suggests that this is the case. Its too soon to know what happens to vaccine efficacy beyond six months in the double vaccinated, but its likely to reduce further.

Another important factor is the variant of the virus that youre facing. The reductions in risk above were calculated largely by testing vaccines against the original form of the coronavirus.

But when facing the alpha variant, data from Public Health England suggests that two doses of the Pfizer vaccine is slightly less protective, reducing the risk of getting COVID-19 symptoms by 93%. Against delta, the level of protection falls even further, to 88%. The AstraZeneca vaccine is also affected this way.

The COVID Symptom Study backs all of this up. Its data suggests in the two to four weeks after receiving your second Pfizer jab, youre around 87% less likely to get COVID-19 symptoms when facing delta. After four to five months, that figure falls to 77%.

Its important to remember that the above figures refer to average risk reduction across a population. Your own risk will depend on your own levels of immunity and other person-specific factors (such as how exposed you are to the virus, which might be determined by your job).

Immune fitness typically reduces with age. Long-term medical conditions may also impair our response to vaccination. Older people or people with compromised immune systems may therefore have lower levels of vaccine-induced protection against COVID-19, or may see their protection wane more quickly.

Its also worth remembering that the most clinically vulnerable received their vaccines first, possibly over eight months ago, which may heighten their risk of experiencing a breakthrough infection due to protection waning.

Vaccines still vastly reduce your chances of getting COVID-19. They also to an even greater degree protect against hospitalisation and death.

However, its concerning seeing breakthrough infections, and the worry is that they might increase if vaccine protection does, as suspected, fall over time. Hence the UK government is planning to give a booster dose to those most vulnerable, and is also considering whether boosters should be given more widely. Other countries, including France and Germany, are already planning on offering boosters to groups considered to be at higher risk from COVID-19.

But even boosters end up being used, this shouldnt be interpreted as vaccines not working. And in the meantime, its essential to promote vaccination to all those eligible who have not yet been vaccinated.

View post:

4 factors that raise the risk of you catching COVID - even if you have been vaccinated - World Economic Forum

Endemic Covid-19 Has Arrived in Portugal. This Is What It Looks Like. – The Wall Street Journal

October 25, 2021

LISBONIn this soccer-crazed capital of a soccer-obsessed nation, the stadiums are full again. Portugal, a country ravaged earlier in the year by the Delta variant of the coronavirus, now has the highest Covid-19 vaccination rate in Europe and offers a glimpse of a country trying to come to grips with what is increasingly looking like an endemic virus.

Tens of thousands of screaming soccer fans crammed into the Estadio da Luz here Wednesday to watch hometown favorites Benfica take on Bayern Munich. They amassed on the subway to the stadium, at the entrance as officials patted them down and, after the game, at food trucks where they downed sandwiches and beer as they tried to forget the drubbing their team had just received.

Read more from the original source:

Endemic Covid-19 Has Arrived in Portugal. This Is What It Looks Like. - The Wall Street Journal

Coronavirus in Illinois: 15,131 New COVID Cases, 183 Deaths, 209K Vaccinations in the Past Week – NBC Chicago

October 23, 2021

Illinois health officials on Friday reported 15,131 new COVID-19 cases in the past week, along with 183 additional deaths and over 209,651 new vaccine doses administered.

In all, 1,680,908 cases of coronavirus have been reported in the state since the pandemic began, according to the latest data from the Illinois Department of Public Health. The additional deaths reported this week bring the state to 25,590 confirmed COVID fatalities.

The state has administered 773,791 tests since last Friday, officials said, bringing the total to more than 34 million tests conducted during the pandemic.

The states seven-day positivity rate on all tests dropped to 2.2% from 2.5% last week, officials said. The rolling average seven-day positivity rate for cases as a percentage of total tests remained at 2% over the past week.

Over the past seven days, a total of 209,651doses of the coronavirus vaccine have been administered to Illinois residents. The latest figures brought the states average to 29,950 daily vaccination doses over the last week, per IDPH data.

More than 15.2 million vaccine doses have been administered in Illinois since vaccinations began in December. More than 54% of Illinois resident are fully vaccinated against COVID-19, with more than 69% receiving at least one dose.

As of midnight Thursday, 1,277 patients were hospitalized due to COVID in the state. Of those patients, 323 are in ICU beds, and 152 are on ventilators.

Go here to see the original:

Coronavirus in Illinois: 15,131 New COVID Cases, 183 Deaths, 209K Vaccinations in the Past Week - NBC Chicago

What Previous Covid-19 Waves Tell Us About the Virus Now – The New York Times

October 23, 2021

After another brutal spike in coronavirus cases and deaths this summer fueled by the Delta variant infections are declining in the United States, down 50 percent from their peak in September.

Experts say what comes next is hard to predict, and we often do not know why the virus spreads the way it does. But looking back at the outbreak so far can provide some clues about how the virus may spread in the future.

Average cases per 100,000 people

Summer 2020

June August

Fall 2020

September November

Winter

December February

Spring 2021

March May

Summer and Fall 2021

June Oct. 20

Note: Most Nebraska counties did not report data during the summer of 2021.

The country has suffered through five waves of the pandemic now, depending on how you count. Each of these waves has a different complexity and pattern, said Alessandro Vespignani, the director of the Network Science Institute at Northeastern University in Boston.

During the first wave, for instance, strict stay-at-home measures and drastic changes in behavior may have stalled the virus for a time. Last fall, with those measures and behavior comparatively relaxed, record-breaking surges in the Midwest rippled outward to the South and both coasts. By the time the highly contagious Delta variant fueled a wave across the country this summer, vaccines were widely available, shifting the pattern once again.

Vaccines have clearly changed which places have been hit and how much theyve been hit, said Jennifer Nuzzo, an epidemiologist at Johns Hopkins University.

Below is a look at five times that the U.S. case curve hit a peak, and the lessons and insights experts have gleaned from each wave.

Outbreaks in

meatpacking facilities

Outbreaks in

meatpacking facilities

Outbreaks in

meatpacking facilities

In the spring of 2020, the first wave hit a few areas particularly hard, including New York City, New Orleans and Albany, Ga. A lot came down to random chance insofar as where the virus struck first, experts said, though population density and transportation hubs may have played a role.

Tests were hard to come by during this period, so cases were drastically underreported. But death data indicates the Northeasts outbreak was one of the worst of the whole pandemic one in about 400 New York City residents died within the span of two months.

Early stay-at-home orders and widespread, drastic behavioral changes flattened the curve in those outbreaks, however, preventing the coronavirus from rippling across the country in waves, the way it would in later surges.

While hospitals overflowed in the Northeast corridor, nearby areas like Maine did not see large outbreaks. Isolated hot spots broke out largely in places where people were unable to socially distance, like nursing homes, prisons and meatpacking plants.

I think its easy to miss how bad things could have gotten and how much better we did than we could have largely because of the lockdowns, said Justin Lessler, a professor of epidemiology at the University of North Carolina.

Outbreaks on

Native American

reservations

Outbreaks on

Native American

reservations

Cases surged again in the summer of 2020, but this time Sun Belt states suffered the worst outbreaks. Many states that set new records for cases and deaths were also those that reopened first, including South Carolina, Alabama, Georgia and Mississippi. Experts say seasonality perhaps the Sun Belts summer heat driving people indoors may also have been a factor.

The summer surge slammed many metropolitan areas of the South and Southwest, including Houston, Miami and Phoenix. Without tight virus restrictions in place, the virus spread outward into suburbs and exurbs. By the end of the summer, most of the worst outbreaks were occurring in rural areas.

If you think of the spring wave in 2020, it was more pointlike around urban areas. In the other waves, you see more of a general flow, Dr. Vespignani said, Like when you throw a stone in a pond.

The flow of cases is clearer in the surge that began in the Upper Midwest in September 2020. North and South Dakota had few virus restrictions in place to contain an outbreak, and both states had particularly bad spikes. One in 10 residents tested positive for the virus in the fall in North Dakota, and experts think many more cases went undetected.

From there, the outbreak expanded beyond the Midwest, reaching both coasts and stretching down to the South in a devastating wave. The country saw more daily cases and deaths in January than any other time before or since.

You do see this movement, almost like its moving from county to county, said Jeffrey Shaman, an infectious disease epidemiologist at Columbia University, who said researchers found community-to-community transmission played an important role in virus spread during the 2009 H1N1 pandemic. But Dr. Shaman said factors other than proximity could have also played an important role with Covid.

Disparate communities may have similar school opening dates, for instance, experience the same cold fronts, or share similar behavior patterns, all of which could lead to independent outbreaks at the same time.

When youre looking at anything after October of last year, the virus is everywhere. It didnt need to be reintroduced, Dr. Shaman said.

Then, in one community after another, cases fell often as quickly as they had risen. A sharp fall after a peak is not uncommon during epidemics, experts said. When a virus rapidly spreads through a community, it eventually runs out of people to infect.

By Spring 2021, U.S. cases had retreated far from their winter peak. At the same time, a more-contagious variant that had fueled an enormous surge in the United Kingdom, called Alpha, was quickly becoming dominant in the United States.

Michigan saw a large surge in cases and deaths, worrying experts that the variant would cause a similar nationwide outbreak. Instead, the virus seemed to stop at the Michigan border in May.

Epidemiologists still do not know why Michigan was unlucky or why the outbreak did not spread to neighboring states. But some noted that it took place right around when all adults first became eligible for the vaccine, and before social distancing behavior loosened significantly.

Its possible that people became more cautious during the resurgence, slowing the spread, said Dr. Lessler, the University of North Carolina epidemiologist. Then vaccines helped stamp it out.

Case and death records

broken across the South

Case and death records

broken across the South

In June, U.S. coronavirus cases were at a low point not seen since the beginning of the pandemic, and nearly half the population had received at least one shot. States lifted virtually all virus restrictions and people relaxed their behavior in celebration.

The timing proved disastrous, especially for areas with lower vaccination rates. Another variant, this time Delta, took hold and quickly grew to account for a majority of U.S. cases. Missouri saw the first big surge of the Delta wave.

Thats where the fire was ignited; then the fire started to spread to other places, Dr. Vespignani said.

Soon, that outbreak moved across Arkansas, then Louisiana, both states with low vaccination rates. Florida became another early Delta hot spot. By the end of August, most states in the South had hit new records for daily cases or deaths and the virus turned northward, causing surges in the upper Midwest and Mountain West.

While the Delta wave rolled across much of the country, some places were relatively spared.

That fire was never able to get, for instance, into the Northeast corridor, Dr. Vespignani said. Its where theres one of the highest vaccination rates. Its like theres a wall.

Some experts say that the vaccination campaign and much of the country having already experienced several waves of outbreaks which have conferred some immunity to those who were infected and recovered have made them cautiously optimistic for the winter.

Dr. Lessler, who helps run the Covid-19 Scenario Modeling Hub, a consortium of research groups that model the future of the outbreak, said none of the groups forecast a substantial winter peak in the United States this year.

We might see a little bump in cases, and of course people could radically change behavior or we could see a variant, Dr. Lessler said, but he added that he did not think a substantial peak was likely.

All the same, there are bound to remain places where the virus can spread, as each new wave has shown. And questions still remain about how long immunity will last.

The difference between the Michigan Alpha wave in Spring 2021 and the Delta wave is really telling you that the wall that youve built might work for one variant, but it might not be enough for the next one, Mr. Vespignani said. There might be another variant that is more transmissible and with more immune evasion. Thats why we need to build the wall as high as possible.

Follow this link:

What Previous Covid-19 Waves Tell Us About the Virus Now - The New York Times

COVID-19: What you need to know about the coronavirus pandemic on 22 October – World Economic Forum

October 23, 2021

Confirmed cases of COVID-19 have passed 242.4 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.92 million. More than 6.76 billion vaccination doses have been administered globally, according to Our World in Data.

The US Centers for Disease Control and Prevention has recommended COVID-19 vaccine booster shots for the Moderna and Johnson & Johnson jabs. They also said Americans can choose a different shot from their original inoculation as a booster.

The US has called on all World Trade Organization (WTO) members to support an intellectual property waiver for COVID-19 vaccines.

New Zealand has set a 90% vaccination target to end its strict COVID-19 restrictions, Prime Minister Jacinda Ardern announced yesterday.

Lockdown restrictions have been eased in Melbourne, Australia, with pubs, restaurants and hair salons reopening.

Bavaria's leader, Markus Soeder, said yesterday that Germany should not let its COVID-19-related state of emergency expire as cases rise again.

Thailand is set to allow quarantine-free travel from 46 countries from 1 November, Prime Minister Prayuth Chan-ocha announced Thursday.

The World Health Organization (WHO) has urged the G20 to step up donations of COVID-19 vaccine doses to the global south.

The WHO also said COVID-19 may have killed between 80,000 and 180,000 healthcare workers up to May of this year - and insisted they be prioritized for vaccination.

Daily new confirmed COVID-19 cases per million people in selected countries.

Image: Our World in Data

A booster dose of the Pfizer/BioNTech COVID-19 vaccine was 95.6% effective against the disease when compared to a vaccinated group that did not get the third shot, data from a large study released by the companies has shown.

The companies in a release said the booster was tested on 10,000 participants aged 16 and older who had received two doses in its earlier trials. A booster administered about 11 months after the second shot had a favourable safety profile and worked against the highly contagious Delta variant of the coronavirus, they said. The data has not been submitted for peer review.

Pfizer and BioNTech said they would submit detailed results of the trial for peer-reviewed publication to the US Federal Drug Administration, the European Medicines Agency and other regulatory agencies as soon as possible.

The COVID Response Alliance for Social Entrepreneurship is a coalition of 85 global leaders, hosted by the World Economic Forum. Its mission: Join hands in support of social entrepreneurs everywhere as vital first responders to the pandemic and as pioneers of a green, inclusive economic reality.

Its COVID Social Enterprise Action Agenda, outlines 25 concrete recommendations for key stakeholder groups, including funders and philanthropists, investors, government institutions, support organizations, and corporations. In January of 2021, its members launched its 2021 Roadmap through which its members will roll out an ambitious set of 21 action projects in 10 areas of work. Including corporate access and policy change in support of a social economy.

For more information see the Alliance website or its impact story here.

The move of social interaction and mixing indoors as the Northern Hemisphere winter sets in is driving a rise in COVID-19 infections in many countries across Europe, the Executive Director of the World Health Organization's Health Emergencies Programme, Dr Mike Ryan, said yesterday.

"Most of those restrictions are now not in place anymore in many countries. And we're seeing that coincide with the winter period in which people are moving inside as the cold snaps appear," Ryan told a news briefing.

"The question remains as to whether or not we will have the same experience as last year with health systems coming once again under pressure."

Written by

Joe Myers, Writer, Formative Content

The views expressed in this article are those of the author alone and not the World Economic Forum.

More here:

COVID-19: What you need to know about the coronavirus pandemic on 22 October - World Economic Forum

COVID-19: Top news stories about the coronavirus pandemic as on 21 October – World Economic Forum

October 23, 2021

Confirmed cases of COVID-19 have passed 242 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.92 million. More than 6.72 billion vaccination doses have been administered globally, according to Our World in Data.

New Zealand has reported a record daily rise in COVID19 cases for the second time in three days, with 102 new infections.

Britain's health minister Sajid Javid has resisted calls from doctors for a return of restrictions, a so-called 'Plan B', but warned that could change if more people did not take up the offer of vaccination. The country reported 223 new deaths from COVID-19 on Tuesday, the highest daily figure since March, and cases are the highest in Europe.

It came as a descendant of the the Delta COVID-19 variant was being tested in the UK to assess the level of threat it poses. But it's not yet considered a variant of concern, according to the BBC.

Ukraine has also reported a record daily rise in new COVID-19 cases and COVID-19-related deaths, with 22,415 new cases and 546 deaths.

The United States has now donated more than 200 million COVID-19 vaccine doses to more than 100 countries, the White House announced.

Japan's Shionogi & Co Ltd has announced Phase II/III trials for its COVID-19 vaccine candidate.

France's lower house of parliament voted to approve the extension of COVID-19 health pass measures until at least 31 July, 2022. The pass shows the holder is vaccinated against COVID-19, or has recently tested negative.

The Pan American Health Organization has called on countries to grant entry to vaccinated travellers regardless of which shot they received, to prevent discrimination and facilitate business.

Poland plans to make COVID-19 vaccine booster doses available to all adults over the next few weeks, Prime Minister Mateusz Morawiecki, said.

The Czech Republic is set to introduce new restrictions, due to the rise in COVID-19 cases.

The US Food and Drug Administration has approved booster doses of the COVID-19 vaccines from Moderna and Johnson & Johnson. It also said Americans could choose a different shot from their original inoculation for their booster.

The World Health Organization has warned that the COVID-19 pandemic will go on longer than necessary because of vaccine inequity. It means it could 'easily drag deep into 2022'.

How COVID-19 cases are rising and falling a round the world.

Image: Our World in Data

India's immunization campaign has covered three-quarters of its 944 million adults with at least one dose, but only 31% with two. The government wants all adults to get vaccinated this year.

"India scripts history," Prime Minister Narendra Modi said on Twitter. "We are witnessing the triumph of Indian science, enterprise and collective spirit of (1.3 billion) Indians."

Nearly 90% of the vaccines administered in India have come from the Serum Institute of India (SII), which produces a licensed version of the AstraZeneca drug. SII has more than tripled its capacity since April and can now produce 220 million vaccine doses a month.

Each of our Top 50 social enterprise last mile responders and multi-stakeholder initiatives is working across four priority areas of need: Prevention and protection; COVID-19 treatment and relief; inclusive vaccine access; and securing livelihoods. The list was curated jointly with regional hosts Catalyst 2030s NASE and Aavishkaar Group. Their profiles can be found on http://www.wef.ch/lastmiletop50india.

Top Last Mile Partnership Initiatives to collaborate with:

People vaccinated against COVID-19 are highly unlikely to die of the disease unless very old and already badly ill before getting it, a study in Italy showed on Wednesday.

The study by the National Health Institute (ISS), contained in a regular ISS report on COVID-19 deaths, shows the average age of people who died despite being vaccinated was 85. On average they had five underlying illnesses.

The average age of death among those not vaccinated was 78, with four pre-existing conditions. Cases of heart problems, dementia and cancer were all found to be higher in the sample of deaths among those vaccinated.

The analysis, carried out from Feb. 1 to Oct. 5 this year, studied the medical records of 671 unvaccinated COVID fatalities and 171 fully vaccinated ones.

Written by

Joe Myers, Writer, Formative Content

The views expressed in this article are those of the author alone and not the World Economic Forum.

Go here to see the original:

COVID-19: Top news stories about the coronavirus pandemic as on 21 October - World Economic Forum

Can new variants of the coronavirus keep emerging? – ABC News

October 23, 2021

The coronavirus that caused the pandemic can keep evolving as long as people are still getting infected, but that doesnt mean new variants will emerge as regularly or that theyll be more dangerous

By CHRISTINA LARSON AP Science Writer

October 21, 2021, 5:05 AM

3 min read

WASHINGTON -- Can new variants of the coronavirus keep emerging?

Yes, as long as the virus that caused the pandemic keeps infecting people. But that doesnt mean new variants will keep emerging as regularly, or that theyll be more dangerous.

With more than half the world still not vaccinated, the virus will likely keep finding people to infect and replicating inside them for several months or years to come. And each time a virus makes a copy of itself, a small mutation could occur. Those changes could help the virus survive, becoming new variants.

But that doesnt mean the virus will keep evolving in the same way since it emerged in late 2019.

When a virus infects a new species, it needs to adapt to the new host to spread more widely, says Andrew Read, a virus expert at Pennsylvania State University.

According to the Centers for Disease Control and Prevention, the delta variant is twice as contagious as earlier versions of the virus. And while it could still mutate to become more infectious, it probably wont double its transmission rate again, says Dr. Adam Lauring, a virus and infectious disease expert at the University of Michigan.

Weve seen a stage of rapid evolution for the virus. Its been harvesting the low-hanging fruit, but theres not an infinite number of things it can do, Lauring says.

Its possible that the virus could become more deadly, but there isnt an evolutionary reason for that to happen. Extremely sick people are also less likely to socialize and spread the virus to others.

Experts are watching to see whether emerging variants could be better at evading the protection people develop from vaccination and infections. As more people get the shots, the virus would have to be able to spread through people who have some immunity for it to survive, says Dr. Joshua Schiffer, a virus expert at the Fred Hutchinson Cancer Research Center.

The virus could take on a mutation that makes the immune response less effective, he says.

If that happens, scientists may recommend that vaccine formulas be updated periodically, just as annual flu shots are.

The AP is answering your questions about the coronavirus in this series. Submit them at: FactCheck@AP.org. Read more here:

Is the delta variant of the coronavirus worse for kids?

Do the COVID-19 vaccines affect my chances of pregnancy?

Am I fully vaccinated without a COVID-19 vaccine booster?

Read the original here:

Can new variants of the coronavirus keep emerging? - ABC News

Page 458«..1020..457458459460..470480..»